Gabelli Funds »

4d Molecular Therapeutics In shares owned by Gabelli Funds

Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by Gabelli Funds from 13F filings

Historical chart of Gabelli Funds investment in 4d Molecular Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including 4d Molecular Therapeutics In held by Gabelli Funds consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in 4d Molecular Therapeutics In by Gabelli Funds

Quarter filed Position value Share count Share price at filing
2025-12-31 $90k 12k 7.50

More positions owned by Gabelli Funds

Microsoft Corp Equity (MSFT)
Nvidia Corp Equity (NVDA)
Newmont Corp Equity (NEM)
Mastercard Inc - A Equity (MA)
Ametek Equity (AME)
National Fuel Gas Equity (NFG)
American Express Equity (AXP)
Nextera Energy Equity (NEE)
Gatx Corp Equity (GATX)
Mueller Industries Equity (MLI)
Bank Of New York Mellon Corp Equity (BK)
Amazon.com Equity (AMZN)
Crane Equity (CR)
Kkr & Co Equity (KKR)
Sony Group Corp - Sp Depository Recei (SONY)

View all positions for Gabelli Funds

Top funds holding 4d Molecular Therapeutics In

BVF
RA Capital Management
Goldman Sachs Group
BlackRock
Novo A/S
Vanguard Group
State Street Corporation
Henderson Group
Federated Investors
Point72 Asset Management
Millennium Management
Armistice Capital
Geode Capital Management
Evergreen Quality Fund GP
Deutsche Bank Aktiengesellschaft

View all funds holding 4d Molecular Therapeutics In